The Bio + Health Fintech Thesis
Healthcare-specific fintech companies are tackling incumbents entrenched in a $4 trillion market. Expect innovation in everything from insurance to care delivery to platform services.
Featured
Healthtech x Fintech’s Biggest Prize: The Financial Operating System for Healthcare
Marc Andrusko, Annie Collins, David Haber, Daisy Wolf, and Julie Yoo
Payvidors, Unbundled: Opportunities in Healthcare Fintech
Marc Andrusko, David Haber, Daisy Wolf, and Julie Yoo
All The Bio + Health Fintech Thesis News & Content
is a general partner on the Bio + Health team, where she leads investments into companies that are transforming how we access, pay for, and experience healthcare.
is a partner at Andreessen Horowitz, where he focuses on B2B AI applications and fintech.
is a general partner at Andreessen Horowitz, where he focuses on technology investments in B2B software and financial services.
is a partner at Andreessen Horowitz, where she leads investments in health technology.
is an investing partner on the Bio + Health team, focused on healthtech.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.